07 September 2016
A new report by visiongain predicts that the Advanced Wound Care market will reach $17.7bn in 2020. This forecast and others appear in Advanced Wound Care Market Forecast 2016-2026: Revenue Prospects for Active Wound Care Dressings, Wound Care Devices and Wound Care Biologics published in April 2016. Visiongain is a business information provider based in London, UK.
The Advanced Wound Care Market Forecast 2016-2026 report examines the current and future trends in the Advanced Wound Care Market with particular focus on recent pivotal developments in the sector involving product launches, company acquisitions, and changes in regulatory and reimbursement policies. These developments in addition to changes in population demographics are changing the landscape of advanced wound care.
Wound Dressings are applied to a wound to promote healing and prevent further harm. A dressing is designed to be in direct contact with the wound. Wound dressings are a fundamental part of wound care in general. A dressing does not heal the wound; it provides an optimal environment for healing to take place. Advanced wound care encompasses the following product segments: active wound dressings, wound care devices, and wound care biologics.
The advanced wound care market is impacted by the ageing population, rising prevalence of diabetes and obesity, and growing patient awareness as well as pressure on healthcare systems to reduce hospital stays and treatment costs. The advanced wound care market will be increasingly expected to innovate in order to meet these demands.
In this report, we examine in detail the factors which are driving the Advanced Wound Care market growth and the key companies currently operating in the advanced wound care market including their product pipelines. We also examine key national markets and discuss trends and variations within these markets, alongside an analysis of advanced wound care products type their relative strengths.
The Advanced Wound Care categories examined in this report are: active wound care dressings, wound care devices, and wound care biologicals. National Markets focused on are the US, China, Japan, EU5 (Germany, UK, Italy, France and Spain), Brazil, Russia, India and South Korea.
Using both primary and secondary research, forecasts have been built for the major submarkets, leading products and leading national and regional markets, accompanied by text giving a thorough explanation of events thought to shape the market currently and in the future.
Also included is analysis of the current leading players in the Advanced Wound Care Market. Historical financial performance (where available) is analysed, along with a breakdown of each company’s leading products, and recent merger & acquisition information, with an analysis of news that may influence the course of the company.
The report discusses selected leading companies which hold significant shares of the market. These companies include Smith & Nephew, Acelity, Molnlycke, Coloplast, ConvaTec, and Organogeneis. Visiongain’s report also discusses key economic points, commercial news, and analysis of strengths, weaknesses, opportunities and threats.
Advanced Wound Care Market Forecast 2016-2026: Revenue Prospects for Active Wound Care Dressings, Wound Care Devices and Wound Care Biologics adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on email@example.com
Tel: +44 (0) 20 7336 6100
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.
Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.
10 September 2019
The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.
09 September 2019
Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.
05 September 2019
Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.